|
Originally published In Press as doi:10.1074/jbc.M408360200 on September 27, 2004
J. Biol. Chem., Vol. 279, Issue 50, 51749-51759, December 10, 2004
The Methylerythritol Phosphate Pathway Is Functionally Active in All Intraerythrocytic Stages of Plasmodium falciparum*
María B. Cassera ,
Fabio C. Gozzo¶,
Fabio L. D'Alexandri ,
Emilio F. Merino ,
Hernando A. del Portillo ||,
Valnice J. Peres ,
Igor C. Almeida ||,
Marcos N. Eberlin¶,
Gerhard Wunderlich ,
Jochen Wiesner**,
Hassan Jomaa**,
Emilia A. Kimura , and
Alejandro M. Katzin ||
From the
Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, 05508-900 São Paulo, Brazil, the ¶Thomson Mass Spectrometry Laboratory, Institute of Chemistry, State University of Campinas, 13083-970 Campinas, Brazil, and the **Institute of Biochemistry, Justus-Liebig-University, D-35392, Giessen, Germany
Two genes encoding the enzymes 1-deoxy-D-xylulose-5-phosphate synthase and 1-deoxy-D-xylulose-5-phosphate reductoisomerase have been recently identified, suggesting that isoprenoid biosynthesis in Plasmodium falciparum depends on the methylerythritol phosphate (MEP) pathway, and that fosmidomycin could inhibit the activity of 1-deoxy-D-xylulose-5-phosphate reductoisomerase. The metabolite 1-deoxy-D-xylulose-5-phosphate is not only an intermediate of the MEP pathway for the biosynthesis of isopentenyl diphosphate but is also involved in the biosynthesis of thiamin (vitamin B1) and pyridoxal (vitamin B6) in plants and many microorganisms. Herein we report the first isolation and characterization of most downstream intermediates of the MEP pathway in the three intraerythrocytic stages of P. falciparum. These include, 1-deoxy-D-xylulose-5-phosphate, 2-C-methyl-D-erythritol-4-phosphate, 4-(cytidine-5-diphospho)-2-C-methyl-D-erythritol, 4-(cytidine-5-diphospho)-2-C-methyl-D-erythritol-2-phosphate, and 2-C-methyl-D-erythritol-2,4-cyclodiphosphate. These intermediates were purified by HPLC and structurally characterized via biochemical and electrospray mass spectrometric analyses. We have also investigated the effect of fosmidomycin on the biosynthesis of each intermediate of this pathway and isoprenoid biosynthesis (dolichols and ubiquinones). For the first time, therefore, it is demonstrated that the MEP pathway is functionally active in all intraerythrocytic forms of P. falciparum, and de novo biosynthesis of pyridoxal in a protozoan is reported. Its absence in the human host makes both pathways very attractive as potential new targets for antimalarial drug development.
Received for publication, July 23, 2004
, and in revised form, September 22, 2004.
* This work was supported in part by grants from the Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico, PRONEX, and UNDP/World Bank/WHO-TDR, European Commission INCO-Dev, 5th Framework Programme Contract ICA4-CT-2001-10078. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains Figs. Data I and II.
Supported by Fundação de Amparo à Pesquisa do Estado de São Paulo.
|| Research fellows from Conselho Nacional de Desenvolvimento Científico e Tecnológico.
 To whom correspondence should be addressed: Laboratory of Malaria, Dept. of Parasitology, Institute of Biomedical Sciences, University of São Paulo, Av. Lineu Prestes 1374, 05508-900, São Paulo, SP, Brazil. Tel.: 55-11-3091-7330; Fax: 55-11-3091-7417; E-mail: amkatzin{at}icb.usp.br.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Tahar and L. K. Basco
Molecular Epidemiology of Malaria in Cameroon. XXV. In Vitro Activity of Fosmidomycin and its Derivatives against Fresh Clinical Isolates of Plasmodium falciparum and Sequence Analysis of 1-Deoxy-D-Xylulose 5-Phosphate Reductoisomerase
Am J Trop Med Hyg,
August 1, 2007;
77(2):
214 - 220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. N. Hunter
The Non-mevalonate Pathway of Isoprenoid Precursor Biosynthesis
J. Biol. Chem.,
July 27, 2007;
282(30):
21573 - 21577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Strohmeier, T. Raschle, J. Mazurkiewicz, K. Rippe, I. Sinning, T. B. Fitzpatrick, and I. Tews
Structure of a bacterial pyridoxal 5'-phosphate synthase complex
PNAS,
December 19, 2006;
103(51):
19284 - 19289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gengenbacher, T. B. Fitzpatrick, T. Raschle, K. Flicker, I. Sinning, S. Muller, P. Macheroux, I. Tews, and B. Kappes
Vitamin B6 Biosynthesis by the Malaria Parasite Plasmodium falciparum: BIOCHEMICAL AND STRUCTURAL INSIGHTS
J. Biol. Chem.,
February 10, 2006;
281(6):
3633 - 3641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Wrenger, M.-L. Eschbach, I. B. Muller, D. Warnecke, and R. D. Walter
Analysis of the Vitamin B6 Biosynthesis Pathway in the Human Malaria Parasite Plasmodium falciparum
J. Biol. Chem.,
February 18, 2005;
280(7):
5242 - 5248.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|